Press Releases
Teva and Antares Pharma Announce Launch of Generic Imitrex...
Teva Pharmaceutical Industries Ltd and Antares Pharma, Inc. announced the launch of the generic equivalent to Imitrex®1 (sumatriptan succinate) injection, 4 mg and 6 mg...
Press Releases
Teva and Antares Pharma Announce Launch of Generic Imitrex...
Teva Pharmaceutical Industries Ltd. and Antares Pharma, Inc. announced the launch of the generic equivalent to Imitrex injection, 4 mg and 6 mg single-dose, prefilled...
Press Releases
Teva Pharmaceutical Receives Positive CHMP Opinion on CINQAERO
Teva Pharmaceutical Industries Ltd announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorization for...
Press Releases
Mylan Launches Generic Version of Glaxo’s Avodart in U.S
Mylan N.V. announced the U.S. launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart® Capsules. Mylan received final approval from the U.S....
Press Releases
Astellas Pharma Inc Ties Up with University of Tokyo...
The Institute of Medical Science, the University of Tokyo and Astellas Pharma Inc. announced that they have signed a new collaborative development agreement on the...
Press Releases
Key exhibitors and industry partners show strong support for...
3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform Established as Asia’s leading...
Press Releases
Calixar and University of Avignon to launch new research...
Calixar, the French biotech company specialized in the native isolation of membrane therapeutic targets/antigens and the French University of Avignon-Bio-organic Chemistry and Amphiphilic Systems Team...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.